Our coverage is unrivalled in its depth, geographic scope and local insights. We enable you to make informed and strategic decisions in an ever-changing and highly competitive market.
Our medical device intelligence covers 16 key therapy areas and is available through comprehensive device modules to offer clients complete flexibility of choice.
We produce thousands of quantitative and qualitative reports annually, instantly available, to help you make more informed decisions quickly.
Our Intelligence Centers offer constantly updated data, investigative news, analysis and tools that slot seamlessly into your workflow to help you decode the future.
For fully bespoke independent insight with dedicated expert service, our consulting offering combines global capabilities with strong understanding of your local markets.
The prospect of Amazon entering the pharma industry with the acquisition of PillPack will be a troubling development for pharma executives around the globe.
It is therefore a timely moment to re...
Following today’s news (Friday 6 July) that Eisai and Biogen have achieved positive top-line results in their Phase 2 trial for BAN2401 in Alzheimer’s patients,
In a recent survey of global healthcare professionals into the impact of Brexit on the Pharma industry, most participants working for UK-headquartered companies did not expect staff relocation's be...
contact online firstname.lastname@example.org
EMEA: +44 207 832 4399
APAC: +91 40 6616 6809
© GlobalData Plc 2018 | Registered Office: John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK Registered in England No. 03925319